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Abstract
Background: The 22q11.2 deletion syndrome is the most frequent genomic disorder with an
estimated frequency of 1/4000 live births. The majority of patients (90%) have the same deletion of
3 Mb (Typically Deleted Region, TDR) that results from aberrant recombination at meiosis
between region specific low-copy repeats (LCRs).
Methods: As a first step towards the characterization of recombination rates and breakpoints
within the 22q11.2 region we have constructed a high resolution recombination breakpoint map
based on pedigree analysis and a population-based historical recombination map based on LD
analysis.
Results:  Our pedigree map allows the location of recombination breakpoints with a high
resolution (potential recombination hotspots), and this approach has led to the identification of 5
breakpoint segments of 50 kb or less (8.6 kb the smallest), that coincide with historical hotspots.
It has been suggested that aberrant recombination leading to deletion (and duplication) is caused
by low rates of Allelic Homologous Recombination (AHR) within the affected region. However,
recombination rate estimates for 22q11.2 region show that neither average recombination rates in
the 22q11.2 region or within LCR22-2 (the LCR implicated in most deletions and duplications), are
significantly below chromosome 22 averages. Furthermore, LCR22-2, the repeat most frequently
implicated in rearrangements, is also the LCR22 with the highest levels of AHR. In addition, we find
recombination events in the 22q11.2 region to cluster within families. Within this context, the same
chromosome recombines twice in one family; first by AHR and in the next generation by NAHR
resulting in an individual affected with the del22q11.2 syndrome.
Conclusion: We show in the context of a first high resolution pedigree map of the 22q11.2 region
that NAHR within LCR22 leading to duplications and deletions cannot be explained exclusively
under a hypothesis of low AHR rates. In addition, we find that AHR recombination events cluster
within families. If normal and aberrant recombination are mechanistically related, the fact that
LCR22s undergo frequent AHR and that we find familial differences in recombination rates within
the 22q11.2 region would have obvious health-related implications.
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Background
Low copy repeats (LCRs), are 10 to 400 kb long DNA
blocks with a complex internal organization that show
more than 95% identity between copies. Non-allelic
homologous recombination (NAHR) between LCRs has
been seen to mediate deletions and duplications in many
genomic disorders. All of this supports the view that LCRs
are essential players in a common mechanism that causes
most genomic syndromes [1]. The 22q11.2 region con-
tains at least 8 LCR22s, four of which are localized within
or flanking the most frequent deletions. These LCR22s
have been labeled from centromere to telomere: LCR22-2
(or LCR22-A); LCR22-3a (or LCR22-B); LCR22-3b (or
LCR22-C); and LCR22-4 (or LCR22-D) [2-4].
The 22q11.2 region undergoes a great amount of germline
and somatic rearrangements, and can be classified as one
of the most unstable regions of the human genome. As
shown in Figure 1, many congenital anomalies are caused
by rearrangements within the 22q11.2 region and practi-
cally all deletions, duplications and translocations show
breakpoints within LCR22s. The del22q11 syndrome is
the most frequent of all of these with an estimated de novo
frequency of 1/4000 live births and it incorporates classi-
cal clinical disorders such as DiGeorge syndrome,
Conotruncal Anomaly Face syndrome, or Velocardiofacial
syndrome (DG, MIM 188400; CTF, MIM 217095; VCF,
MIM 192430) [5].
The great majority of patients suffering of the del22q11.2
syndrome (97–98%) have a proximal breakpoint within
LCR22-2, whereas the distal breakpoint can vary and in
90% of patients it falls within LCR22-4 producing a 3 Mb
deletion (Typical deleted region; TDR); or in 7% of
patients within LCR22-3a producing a 1.5 Mb deletion
(Figure 1) [3,6,7].
Most deletions in the 22q11.2 region are the result of
NAHR between homologous chromosomes (interchomo-
somal recombination), as opposed to NAHR within the
same chromosome (intrachromosomal recombination)
[6,8]. Deletion and duplication in interchromosomal
NAHR are reciprocal products of the same crossover event
and current models predict that they should be equally
frequent. In support of this prediction, recent studies have
found patients with duplications that are the result of
NHAR between the same LCR22s implicated in deletions
(Figure 1) [9,10].
Meiotic allelic homologous recombination (AHR) insures
proper segregation of chromosomes to gametes and
results in the exchange of DNA segments between pairs of
homologous chromosomes without loss or gain of genetic
material. AHR events are not distributed evenly across the
genome and concentrate in hotspots that are 1 to 3 kb in
length. In fact, 80% of recombination is calculated to take
place in 10–20% of the total genome sequence. However,
frequency of recombination within these hotspots can
vary by several orders of magnitude, ranging from rates
below the genome average (0.3 fold) to frequencies that
are far above (120 fold) [11,12].
Not much is known on the relation between AHR and
NAHR within the regions implicated in recurrent genome
rearrangements. NAHR hotspots that have been studied
so far seem to be localized within larger regions that show
low rates of AHR during meiosis [13,14]. Because of this
observation, it has been proposed that mispairing
between non-allelic copies of LCRs may be facilitated by
reduced recombination within these regions, leading to
unequal crossing over between non-allelic LCRs [1].
There are three available methods that can be used to
characterize recombination in the human genome: single-
sperm typing, population-based linkage disequilibrium
(LD) maps and pedigree-based maps. Single-sperm typing
is the method of choice to infer contemporary recombina-
tion rates at a very fine scale because it allows typing of
large sample sizes. However, single sperm typing detects
recombination within short intervals and needs previous
information on the location of recombination hotspots
and it does not detect female recombination. Population-
based LD maps provide an overview of the recombina-
tional history reflecting transmissions from many individ-
uals over thousands of generations and thus reflect only
historical recombination rates. These maps although can-
not distinguish male and female recombination events,
are good predictors of contemporary recombination rates
at a scale larger than 5 Mb and detect most (but not all)
contemporary hotspots [12,15]. Finally, pedigree-based
maps, although inevitably based on relatively few meio-
sis, have been shown to give rough but reliable estimates
of average recombination rates within large regions and to
give an overview of the position of recombination
hotspots [14,16,17]. Furthermore, a unique feature of
pedigree maps is that they allow for the characterization
of sex-specific recombination because female and male
recombination events can be discriminated.
As a first step towards the characterization of recombina-
tion rates and breakpoints within the 22q11.2 region we
have constructed a high resolution recombination break-
point map based on pedigree analysis and a population-
based historical recombination map based on LD analy-
sis.
Methods
Patients, and samples
Samples from patients and their families were obtained
after informed consent. Ethical approval was obtained forBMC Medical Genetics 2007, 8:14 http://www.biomedcentral.com/1471-2350/8/14
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this study from the Committee for Ethical Clinical
Research of the Government of the Balearic Islands
(CEIC). Research was performed in compliance of the
Helsinki declaration.
Position and length of LCR22s
Map construction requires the precise location of low
copy repeats within the studied region. Although this had
been done before [2,3,18], we determined the precise
boundaries of the repeats within the context of the human
genome sequence draft (May 2004 release)[19] to be able
to locate new markers and recombination breakpoints in
reference to each LCR22. For this purpose, 25 kb windows
of genomic sequence that had been filtered out of inter-
spersed sequence repeats (between positions 16 and 23
Mb), were compared with the complete human genome
sequence draft using the BLAT and BLAST programs. This
strategy enabled us to detect identical or near-identical
sequences that were located in other genomic positions
on chromosome 22 or other chromosomes and hence
constituted low copy repeats.
By this approach we identified the boundaries of all the
previously described LCR22s, as well as a new previously
non-described small low copy repeat. This new LCR22 is
approximately 25 kb-long and is positioned between
LCR22-2 and LCR22-3A at positions 18.503114-
18528713 and is composed by a sequence that is dupli-
cated only within LCR22-6 at positions 22045473-
22069076 with a 93% identity. The repeated sequence
includes the 3' end of the ZDHHC8 gene (exons 8–11)
and a predicted gene with an unknown function. Interest-
ingly, the ZDHHC8 gene which encodes a putative trans-
membrane palmitoyltransferase has been proposed to
Map showing recurrent breakpoints of germline and somatic deletions, duplications and translocations that have been  described within the 22q11.2 region Figure 1
Map showing recurrent breakpoints of germline and somatic deletions, duplications and translocations that 
have been described within the 22q11.2 region. Yellow lines indicate the length of deletions and blue lines the length of 
duplications (CES: Cat eye syndrome).BMC Medical Genetics 2007, 8:14 http://www.biomedcentral.com/1471-2350/8/14
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contribute to susceptibility to schizophrenia associated
with the 22q11.2 region [20]. The other repeats were
found to have the following positions and sizes: LCR2
17016923-17384345 (367, 42 KB); LCR3A 18684169-
19068000 (383,381 KB) (this an estimation because of a
gap in the sequence); LCR3B 19353714-19416000
(62,286 KB); LCR4A 19777000-20121932 (344,932 KB);
LCR4B 20137031-20241670 (104,639 KB); LCR5
21276000-21396500 (120,5 KB) and LCR6 22047000-
22153000 (106 KB).
New marker design
New polymorphic simple sequence repeats (CATCH
markers) were identified using the Tandem Repeats Finder
and the RepeatMasker tracks of the May 2004 release of
the human reference sequence available at the University
of Santa Cruz (UCSC) Genome Browser [19]. Once a
repeat was identified in the region of interest, the design
of primers for PCR was performed using the Oligos 9.6
program [21]. Interspersed repetitive sequences identified
by RepeatMasker were avoided when possible as primer
annealing sequences. Finally, sequences flanking the
repeat were checked against the human genome using the
BLAST and BLAT programs [19,22] to ensure it was a sin-
gle copy marker. PCR conditions and annealing tempera-
tures were determined empirically based on program
predictions (see Additional File 1).
Pedigree-based linkage map construction
Fourteen families and a total of 152 genomic DNAs of
family members were typed to detect recombination
events within the 22q11.2 region. Families were Spanish
from Mediterranean regions (Balearic Islands and Catalo-
nia). Ten families included 3 generations or more, and the
other four included both parents and at least three off-
spring. Two of these families had a member affected with
the del22q11.2 syndrome, while the other families had no
known disease associated to the 22q11.2 region. In total,
204 informative meiosis (83 female, 98 male, and 23 of
unknown sex) were typed with 62 different microsatellite
polymorphic markers (see Additional file 1) over a region
spanning 6,5 Mb. Deleted chromosomes were not
counted as informative meiosis because they were the
product of an illegitimate recombination (NAHR) event.
DNAs were initially typed with 6 microsatellite markers
(D22S420, D22S427, D22S264, D22S308, D22S303 and
D22S1174) to determine the most likely haplotypes,
detect recombination events within the 22q11.2 region,
and avoid non-detection of double crossovers. When out-
lying markers D22S420 or D22S1174 were not informa-
tive they were replaced by the nearest informative marker
available. In consequence, the total number of informa-
tive meiosis is 204 between markers D22S427  and
D22S425, but this number decreases towards the out-
flanking regions. Recombination breakpoints were then
positioned by typing all available markers within the
interval where the breakpoint had been initially localized.
Haplotypes were determined with the help of the grand-
parental genotypes, when available, and by minimizing
the number of double crossovers. In three of the families,
the first generation consists of three siblings or more and
haplotypes can be assigned unambiguously, although it
can not be determined if it was a female or a male recom-
bination event. Genetic distances between markers were
calculated by dividing number of recombination events
within the interval by the total number of informative
meiosis for the same interval.
We pooled our data with that of the CEPH website [23]
which includes data for markers flanking but not within
the TDR for the following families: 17, 66, 102, 884,
1331, 1332, 1333, 1334, 1340, 1341,1346, 1347, 1358,
1362, 1408, 1413, 1416, 1420,1423, 1454 (236 meiosis).
In total, within these CEPH families, we identified 33
recombination events, that because of the paucity of
markers, we were not able to narrow down recombination
breakpoints to small sized segments. As an exception, 3
breakpoints were localized to LCR22-2 (2 male and 1
female) and 1 breakpoint to LCR22-4 (male). All this data
was pooled together with that of our linkage map to cal-
culate recombination rates within the 22q11.2 region and
within each of the LCR22s.
Population-based linkage-disequilibrium SNP map and 
hotspot estimation
Population recombination parameters were determined
from data available at the public HapMap Project (public
data release #21 October 2004)[24]. We selected a total of
2074 SNPs between positions 16198487 to 23198486.
Genotypes were recorded for 60 unrelated individuals cor-
responding to parents of the CEPH dataset (northern and
western European ancestry).
Estimation of recombination parameters was done using
the PHASE v2.1.1 software which calculates linkage dise-
quilibrium (LD) patterns among SNP pairs and derives
two parameters for each interval: the population recombi-
nation rate (ρ) which reflects the demographic history of
the population and a measure of how recombination var-
ies within the same interval (λ)[25,26]. To this end we
divided the 22q11.2 region into 15 400-kb non overlap-
ping windows, except for those containing LCR22-2,
LCR22-3A and LCR22-4 that were of 800-kb. An addi-
tional window of 437 kb located within the IGL locus
region was considered.
Two models of variation of recombination were consid-
ered, the general model which is the default model for
PHASE v2.1.1 (option -MR0) and the simple hotspotBMC Medical Genetics 2007, 8:14 http://www.biomedcentral.com/1471-2350/8/14
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model (option -MR1). The first model considers that the
recombination rate in a genomic region is a function of
parameters  ρ and λ. The second model considers that
recombination rate in a genomic region equals ρ, except
in the hotspot region in which recombination rate equals
λρ. We used the default priors for recombination parame-
ters defined in the PHASE v2.1.1 software [25]. For each
input file, we ran PHASE five times and selected the data
from the run with the best average value for the goodness
of fit (option -x5). The final run for the whole dataset was
run 10 times longer to obtain better estimates of the
recombination parameters (option -X10). Data was ana-
lysed from the recombination output file from which we
computed the median of the 1000 draws from the poste-
rior distributions of ρ and λ. We computed ρ at each SNP
interval by the product of λρ. Under the simple hotspot
model, we estimated the posterior probability of both, λ
greater than 10 and λ greater than 100 and computed the
associated Bayes Factor (BF). BF measures the strength of
evidence for a hot spot by computing the probability of
obtaining the data if a hot spot is present divided by the
probability of obtaining the data if a the hot spot is not
present [25]. We considered intervals of the hotspot to
extend from the 5th percentile of the posterior probability
for the left end to the 95th percentile of the posterior
probability for the right end.
Statistical calculations
The expected number of families having 0, 1, 2 and ≥ 3
recombination events in the TDR region was modeled fol-
lowing a Poisson distribution, assuming a random occur-
rence of a recombination event in a family. As the
opportunity to observe a recombination event in a family
depends on the number of meiosis observed, we only con-
sider those families from witch we have observed a mini-
mum of 10 meiosis. From the 18 families that fulfill this
criterion, we estimated a frequency of 1.5 recombination
events per family (18 families, with a mean number of 20
meiosis per family and a total of 27 recombination
events). The observed number of families having 0, 1, 2,
and ≥ 3 recombination events was compared with their
expected values assuming a Poisson distribution with a
chi square test with 2 degrees of freedom. We also tested
for differences among observed and expected values by
the mean distance test of Poissonity proposed by Szekely
and Rizzo [2004]. This test is a goodness-of-fit test based
on the estimator of the cumulative distribution function.
The test statistic is a Cramer-von Mises type of distance
and it is implemented in the R Software by parametric
bootstrap. The poisson.mtest of R was run with 10000
replicates.
Results
Breakpoint distribution
The pedigree map is based on 204 informative meiosis
that were typed with 62 different microsatellite polymor-
phic markers (38 designed for this study; CATCH mark-
ers) (see Additional File 1) over a region spanning 6.58
Mb (Figure 2). This approach led to the detection of 27
single recombination events and no double crossovers.
Markers are not distributed uniformly over the entire
22q11.2 region. Regions with a high marker density, as for
example the Immunoglobulin lambda locus (IGL), have
permitted the location of 5 breakpoints to segments of 54
kb or less (8.6 kb the smallest) (Table 1). Overall, the aver-
age marker density between D22S427 and D22S1174 is
approximately of 1 marker every 85 kb if we exclude the
genomic sequence that corresponds to the repeated DNA
of the LCR22s and the median size of breakpoint intervals
is of 338 kb.
Recombination events do not spread evenly within the
studied region and there are segments where crossovers
tend to cluster and segments with little or no recombina-
tion. Furthermore, we find that we can divide the 22q11.2
region into segments that alternatively undergo male or
female recombination with very little overlap (Figure 2).
The regions that go from position 16.23 to 17.95 Mb
(D22S420-CATCH48), 18.31 to 19.09 Mb (CATCH23-
D22S264) and 20.88 to 22.81 Mb (D22S306-D22S1174)
are female-specific with no male recombination. Seg-
ments between 19.09 and 19.5 (D22S264-D22S311);
19.74 and 20.34 (CATCH38-CATCH35), and 20.58 and
20.81 (D22S539-CATCH29) are sections of exclusively
male recombination. There are only two regions that
present both male and female recombination events,
those between 18.02 and 18.31 (D22S1623-CATCH23)
and 20.81 and 20.89 (CATCH29-CATCH16).
AHR rates in the 22q11.2 region
Average recombination rates in the 22q11.2 region were
calculated by pooling our data with that available for the
CEPH families at the CEPH Genotype database browser
V2.1. In this way, we improved the precision of our esti-
mates by increasing the sample size to 440 meioses and
60 recombination events. Based on these data the sex-
averaged recombination rate for the analyzed region (6.
58 Mb, positions 16233835-2281304) is of 2.1 cM/Mb
(95% confidence intervals (CI): 1.6–2.76). If we concen-
trate on the 3 Mb TDR, the sex-averaged recombination
rate increases to 2.6 cM/Mb (CI: 1.8–4.4). On the other
hand, sex-specific female and male rates in the 6.5 Mb
22q11.2 region are 2.9 cM/Mb (CI: 1.9–4.5) and 1.4 cM/
Mb (CI: 0.7–2.5), respectively. In the TDR sex-specific
rates increase to 4.0 cM/Mb (CI: 2.2–6.9) in females and
2.0 cM/Mb (CI: 0.9–4.2), in males. Neither 22q11.2
recombination rates, nor those of the 3 Mb TDR includedBMC Medical Genetics 2007, 8:14 http://www.biomedcentral.com/1471-2350/8/14
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in the larger 6, 58 Mb region, differ significantly from
chromosome 22 averages described in previous studies
[27,28]. From this we can conclude, that overall AHR
within the 22q11.2 region or within the TDR are not
below chromosome 22 averages.
Our pedigree map allows the location of recombination
breakpoints with a high resolution but sample size does
not permit the accurate measure of recombination rates at
a fine scale. However, recombination rate inaccuracies can
be reduced by decreasing the resolution and for this rea-
son we analyzed recombination rates in 14 intervals of
500 kb each [16]. This analysis provides an estimation of
the variation of contemporary recombination rates within
the 22q11.2 region (Figure 3). We find 3 regions to dis-
play high recombination rates. The first of these regions
has an estimated recombination frequency of 3.2 cM/Mb
(CI: 1.1–8.4), extends from position 17 to17.5 Mb and
includes LCR22-2. The second spans from position 18 Mb
to 19.5 Mb and shows a peak at position 18–18.5 with a
rate of 4.9 cM/Mb (CI: 2.2–11.4). This region includes
LCR22-3A and B. The third region between positions 20.5
and 21 Mb shows the highest calculated recombination
rate of 6.1 cM/Mb (CI: 2.8–12.7), and includes part of the
immunoglobulin light chain (IGL) locus.
Coincidence between breakpoints and historical 
recombination hotspots
An LD map was constructed based on 2074 SNPs from the
HapMap project (3,5 kb resolution) that were analyzed in
400–800 kb windows using the general model for recom-
bination rate variation of the PHASE 2.1.1 software (Table
2 and Figure 4) [25,26]. Regions with a high density of
markers in the pedigree map were used to determine if
contemporary breakpoints coincide with peaks of histori-
cal recombination. The analysis of two of such regions
(17, 80 to 18, 40 and 20,60 to 21,00 Mb) found that small
breakpoint intervals in the pedigree map coincide in all
cases with peaks of historical recombination (Figure 5).
Furthermore, small breakpoint segments can be used to
interrogate if recombination breakpoints that were found
in the pedigree map coincide with historical recombina-
tion hotspots and thus potentially reflect the activity of
contemporary hotspots. When such analysis was per-
formed, we found that 4 out of 5 breakpoint segments
smaller than 54 kb coincide with historical hotspots pre-
dicted by our LD map and those at the UCSC genome
browser based both on HapMap and Perlegen data (Table
1 and Figure 5) [29].
Concordance between AHR and NAHR
LCR22s are frequent sites of illegitimate recombination
that cause deletions and duplications [3-6,9]. To deter-
mine if LCR22s are also sites of frequent AHR meiotic
recombination, we made primer sets that amplify poly-
morphic markers flanking the different LCR22s (Addi-
tional file 1 and Figure 2). Pedigree recombination
analysis shows that LCR22-2 displays the highest recom-
bination rates of all the LCR22s: 4, 54 cM/Mb (CI: 2, 35-
9, 7 cM/Mb); LCR22-3a, shows a recombination rate of
2,76 cM/Mb (CI: 1, 35-5, 2 cM/Mb) and LCR22-4 of 1,91
cM/Mb (CI: 1, 15-6, 0 cM/Mb). No recombination events
were localized within LCR22-5 or LCR22-6.
To assess the support in the HapMap LD map we con-
structed for each LCR22 being "hot" regions for AHR, we
used the PHASE 2.1.1 program (option -MR1) to estimate
the most probable hotspot within each of the 400–800 kb
windows into which the 22q11.2 region was divided. The
program predicts LCR22-2, LCR22-3A and LCR22-4 to
contain the main recombination hotspot of their 800 kb
window (Table 2), but not LCR22-5 and LCR22-6. LCR22-
2 is again the one with the highest recombination inten-
sity (λ = 298; 298 times the background recombination of
Table 1: Genomic features of small regions containing breakpoints in family data
Family data Hotspot prediction from HapMap data (Phase 2.1, MR1 model) Hotspot prediction at UCSCa
Outlying 
markers 
(centromeric
, telomeric)
Position (bp) Size 
crossover 
region
Crossovers 
detected
Hotspot 
boundaries
Hotspot 
with (bp)
Hotspot intensity 
(λ, 95%CI)
Bayes Factor (log) Hotspot 
predicted
Recombination 
intensity (cM/Mb)
λ > 10 λ > 100
CATCH 48
D22S944
17,95198
17,98496
32,98 1 17,963500
17,971900
8400 762 (466:990) 3.00 3.00 Yes 17.36 (Hapmap)
7.02 (Perlegen)
CATCH 42
D22S311
19,449222
19,503575
54,353 1 19,229800
19,237700
7900 2.6 (1:8) -1.45 -3.00 No 3.02 (Hapmap)
0.54 (Perlegen)
CATCH 26
CATCH 30
20,706255
20,740881
34,626 1 20,634600
20,640300
5700 8.5 (1.1:32) -0.54 -2.70 Yes 40.53 (Hapmap)
17.61 (Perlegen)
D22S306
CATCH 16
20,887523
20,896124
8,601 1 20,881700
20,890000
8300 131 (17:307) 3.00 0.09 Yes 10.62 (Hapmap)
46.50 (Perlegen)
CATCH 16
CATCH 28
20,896124
20,929869
33,745 1 -- -- -- -- -- Yes 9.38 (Hapmap)
15.67 (Perlegen)
a based on hotspot information and SNP-based recombination rates available in the UCSC genome browser.BMC Medical Genetics 2007, 8:14 http://www.biomedcentral.com/1471-2350/8/14
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the window that contains LCR22-2) and likelihood
(logBF = 3).
Family clustering of NAHR and AHR events
We analyzed recombination events within several three-
generation families with a member carrying a 3 Mb dele-
tion caused by interchromosomal NAHR between LCR22-
2 and LCR22-4. In one of these families, we found a
grand-maternal AHR event within LCR22-2 that had no
pathological consequences. In the next generation, the
same chromosome involved in this AHR event partici-
pated in a NAHR event causing a 3 Mb deletion (pink hap-
lotype in Figure. 6). Moreover, both events were the
product of female recombination.
This observation suggests that certain haplotypes may be
more prone to undergo AHR and NAHR events within the
22q11.2 region. To test this we analyzed the presence or
absence of recombination events within TDR in families
used to construct the pedigree map. This analysis shows a
non random distribution of recombination events per
family. Families tend to cluster in two extreme groups:
one with no recombination events and another with more
than 3 recombination events in this region. To test for the
statistical significance of this observation we modeled the
expected number of families having 0, 1, 2 and more that
3 recombination events as a Poisson distribution of mean
1.5. In a sample of 18 families, the observed number of
families having 0, 1, 2 and more than 3 recombination
Pedigree-based recombination breakpoint map based on the typing of 62 polymorphic markers (38 designed for this study;  CATCH markers) in 14 extensive families totaling 204 meiosis Figure 2
Pedigree-based recombination breakpoint map based on the typing of 62 polymorphic markers (38 designed 
for this study; CATCH markers) in 14 extensive families totaling 204 meiosis. We localized a total of 27 single 
recombination events. The 22q11.2 region is drawn to scale including the locations of the LCR22s (green boxes) and the posi-
tion of the polymorphic markers used. Blue, red and white lines represent regions to where male (blue), female (red) and 
unknown sex (white) recombination breakpoints have been narrowed down. Genes TBX1 and CRKL that are implicated in the 
clinical manifestations of the del22q11.2 syndrome are shown, as is the IGL locus also mentioned in the text.BMC Medical Genetics 2007, 8:14 http://www.biomedcentral.com/1471-2350/8/14
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events was of 8, 2, 1 and 7, respectively (Figure 7). These
numbers were significantly different from those expected
under a Poisson distribution (4, 6, 4.5 and 2.3, respec-
tively) (χ2 = 13.06, 2 df; P = 0.0016 and Mean distance test
of Poissonity, P = 0.0033). This result shows that certain
families have a higher tendency to recombine within the
TDR region than others.
To explore if there is a genetic basis within the TDR for the
observed differences between families, we analyzed mic-
rosatellite markers that are located within the TDR in indi-
viduals recombining within this region. However, allelic
frequencies were not significantly different in these indi-
viduals from those of the overall population (data not
shown). This indicates that high and low recombining
families do not show different origins for the TDR. There-
fore, although we have found indications that certain
individuals may undergo AHR in the TDR more fre-
quently than others, we have not found any apparent dif-
ferences within the TDR itself between such individuals.
Discussion
The knowledge of the detailed contemporary recombina-
tional traits of a genomic region is based on the localiza-
tion of the exact position of crossovers and the accurate
characterization of recombination frequencies. However,
previously published genetic maps of chromosome 22
provided very little information on the 22q11.2 region
Variation of recombination rates along the 22q11.2 region Figure 3
Variation of recombination rates along the 22q11.2 region. We show 14 intervals of 500 kb and calculated the fre-
quency of recombination (cM/Mb) for each. On the left, in blue we show male recombination rates and on the right, in red, 
female recombination rates. Dotted lines show sex-averaged recombination, while dotted red and blue lines show the female 
and male recombination averages for the entire 22q11.2 region.B
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Table 2: Descriptive data used for the analysis of the Hapmap population-based recombination profile of the 22q11.2 region
Characteristics of windows General model for 
recombination 
(MR0)(1)
Simple hotspot model for recombination (MR1)(2)
Chromosome 
position
Hotspot boundaries(4) 
(chromosome position)
Bayes factor 
(BF)(6) (log BF)
Window begin end Window 
length (bp)
SNPs/
window
SNP 
density (bp/
SNP)
LCR containing 
windows
Population recombi-
nation rate (ρ/bp(3)
Population recombi-
nation rate (ρ/bp(3)
left rigth Hotspot width 
(bp)
Hotspot Inten-
sity(5) (λ)
λ > 10 λ > 100
I 16000790 16396314 395524 126 3139 0.00079688 0.00139749 16192800 16198100 5300 200(70:438) 3.00 0.59
II 16402210 16801972 399762 187 2138 0.00028288 0.00053267 16683800 16691200 7400 28.2(1.2:145) -0.03 -1.13
III 16802997 17601177 798180 275 2902 LCR22-2 0.00020637 0.00044908 17111470 17296800 185330 (LCR22-2) 298(66:955) 3.00 1.05
IV 17603290 17998020 394730 137 2881 0.00004115 0.00007356 17963500 17971900 8400 762(466:990) 3.00 3.00
V 18006919 18406881 399962 157 2548 0.00039653 0.00076869 18032000 18041400 9400 42(1.8:145) 0.21 -1.00
VI 18414421 19205939 791518 173 4575 LCR22-3A 0.00025670 0.00058289 18737180 18897600 160420 (LCR22-3A) 147(12:805) 1.67 -0.38
VII 19215813 19613455 397642 141 2820 LCR22-3B 0.00010245 0.00030662 19229800 19237700 7900 2,6(1:8) 1.45 -3.00
VIII 19624609 20406127 781518 158 4946 LCR22-4 0.00036461 0.00068812 19947500 20081300 133800 (LCR22-4) 188(10:903) 1.26 -0.43
IX 20435862 20835601 399739 129 3099 0.00015527 0.00029812 20634600 20640300 5700 8,5(1,15:32,5) -0.54 -2.70
X 20835924 21235614 399690 81 4934 0.00061587 0.00068451 20881700 20885700 4000 131(417:307) 3.00 0.09
XI 21238221 21625884 387663 68 5701 LCR22-5 0.00051035 0.00087814 21432500 21439900 7400 370(9:890) 1.24 0.39
XII 21640460 22037074 396614 139 2853 0.00007681 0.00018216 21668195 21676200 8005 6(1.1:19) -0.78 -3.00
XIII 22040766 22438098 397332 97 4096 0.00042922 0.00052211 22247500 22250300 2800 702(391:966) 3.00 3.00
XIV 22441140 22840845 399705 124 3223 LCR22-6 0.00010236 0.00013618 22514100 22519600 5500 447(211:780) 3.00 2.22
XV 22844929 23194681 349752 82 4265 0.00002937 0.00002733 23002500 23014000 11500 480(130:898) 3.00 1.63
Total region 16000790 23194681 7193891 2074 3469 0.000290 0.000516
(1) Background population recombination rate (ρ) was estimated for each window using genotype data available at the HAPMAP project for CEU unrelated individuals, genotypes were analyzed by the PHASE v2.1.1 software using the general model for 
recombination rate variation (-MR0 option) after performing 1.000 iterations to estimate posterior distribution of recombination parameters (-X10 option). All the analyses were performed running PHASE five times and selecting the best average value for the 
"goodness of fit" (-x5 option). We computed all the recombination parameters estimates based on the recombination output file, which provides a sample from the posterior distribution of the background recombination rate (ρ) per base pair and the factor by 
which the recombination rate between two adjacent SNPs exceeds the background rate (λ).
(2) The presence of a recombination spot was estimated for each window by the PHASE v2.1.1 software using the simple hotspot model for recombination (-MR1 option) after performing 1000 iterations to estimate posterior distribution of recombination 
parameters (-X10 option), We computed all the recombination parameters estimates based on the hotspot output file, which provides a sample from the posterior distribution of the background recombination rate (ρ) per base pair, the factor by which the 
recombination rate in the hotspot exceeds the background rate (λ) and the left and right ends of the hotspot.
(3) From the estimated recombination parameters we computed the median ρ of each window and the median ρ of the 22q11.2 region by a weighted average of the median ρ of each window.
(4) Hotspot boundaries were considered to extend from the 5th percentile of the posterior probability for the left end to the 95th percentile for the right end.
(5) Of the 1.000 draws from the posterior distribution of λ we computed the median and the 5th and 95th percentile.
(6) From the posterior distribution of λ, we computed the probability of both: λ > 10 and λ > 100 and computed the associated Bayes Factor (BF) to asses the statistical support of a recombination spot. A BF > 10 (Log BF > 1) was taken to indicate the presence 
of a recombination spot, that was considered as a warm spot if BF > 10 (Log BF > 1) computed under P(λ > 10) and hotspot if BF > 10 (Log BF > 1) computed under P(λ > 100).BMC Medical Genetics 2007, 8:14 http://www.biomedcentral.com/1471-2350/8/14
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[27,28]. These maps had been obtained within the context
of the construction of genome-wide genetic maps and the
marker density in the 22q11.2 region was low. In fact,
none of them included markers located within the 3 Mb
region most frequently implicated in the 22q11.2 dele-
tion and duplication syndrome (typically deleted region;
TDR) (Figure 1). In addition, several high resolution maps
based on LD data reflecting historical recombination rates
have been published [12,25,29,30]. However, corre-
spondence between historical and contemporary recom-
bination rates is not perfect which justifies the need for a
recombination map based on breakpoint analysis.
The resolution of a genetic map determines how precisely
we know the position at which a crossover is located and
is limited by the density of polymorphisms and the dis-
tance between the closest markers. On the other hand, the
accuracy of the recombination rate of a particular genomic
segment is a function of the number of meiotic events
studied [16]. The pedigree-based map we present here,
although of limited accuracy (204 meiosis), has a much
higher marker density (1 marker per 85 kb) than other
previous genetic maps of the region [28]. Because of its
high resolution our map allows the localization of cross-
overs to small segments and obtains a comprehensive
overview of regions of high and low recombination and of
potential recombination hotspots. As a result, we have
identified three regions that display higher recombination
rates than the others within 22q11.2: one comprising
LCR22-2, a second LCR22-3A and B, and a third the IGL
locus. In addition, we have seen that male and female
recombination is very compartmentalized, with regions
containing only male or female crossovers with practically
no overlap.
However, the particular traits of the 22q11.2 region war-
rant a point of caution on recombination rates because
there may be inaccuracies in the LCR22 sizes calculated
from the available human genome sequence drafts
(UCSC; May 2004 release): The size of LCR22-3a may not
be exact, as it is an estimation because of a sequence gap.
In addition, recently it has been shown that LCR22-2 and
LCR22-4 can be polymorphic in size in the normal popu-
lation (copy number variations; CNV) and thus certain
individuals may have larger or smaller LCR22s [31].
Population-based LD maps which model historical
recombination rates have been shown to be able to pre-
dict most contemporary recombination hotspots
[17,25,32]. To determine with increased accuracy and res-
olution the recombinational traits of the 22q11.2 region
we have also constructed a population-based LD map
from Hapmap SNP-genotype data (2074 SNPs). This LD
map was used to provide support to predictions made by
the pedigree map. We find coincidence between small
breakpoint segments in the pedigree map and historical
recombination hotspots (Table 1 and Figure 5).
Interchromosomal non-allelic homologous recombina-
tion (NAHR) between LCR22s has been seen to mediate
most of the germline deletions and duplications in the
22q11.2 region. However, not much is known on a possi-
ble relation between normal meiotic recombination
(AHR) and ectopic recombination (NAHR) in regions
implicated in recurrent genome rearrangements. We find
some support for a relation between high rates of AHR
and NAHR in the 22q11.2 region. Our maps show that
LCR22-2, LCR22-3a and LCR22-4 undergo frequent AHR
and that LCR22-5 and LCR22-6 support little or no
recombination. Interestingly, NAHR between the three
LCR22s displaying frequent AHR account for nearly all
described deletions in the 22q11.2 region. It is also sug-
gestive that LCR22-2, the LCR that mediates most dele-
tions and duplications within the 22q11.2 region, is also
the LCR in which we have found the highest AHR rates.
Furthermore, AHR breakpoints detected within LCR22-2
are mostly female and we show through a meta-analysis
of published data that there is a significant excess of
maternal deletions in del22q11.2 syndrome patients
(56%; X2: p = 0, 0238) (Table 3). This result indicates that
there is also a female bias in NAHR causing de novo
22q11.2 deletions.
It has been proposed that LCR22-4 replicates later than
LCR22-2 in chromosomes of maternal origin and that this
favors misalignments between LCR22-2 and LCR22-4
leading to NAHR causing 22q11.2 deletions [33]. This
model predicts that the remaining centromeric part of
LCR22-2 in the deIeted chromosome would be predomi-
nantly of grandmaternal origin. In our case we deter-
mined that the centromeric region had a grandmaternal
origin in 4 of the observed AHR events within LCR22-2,
while 2 cases were not informative (data not shown). This
observation seems to support an influence of late replica-
tion of the maternal chromosome in AHR events, as well
as NAHR events. Nevertheless, when we analyzed three
families that had suffered a NAHR event and a deletion,
and contrary to previous results, only one had the centro-
meric portion of grandmaternal origin (data not shown).
Futhermore, although 90% of the deletion events have
their endpoints within LCR22-2 and 4, we find that the
second highest AHR rate within an LCR22 is in LCR22-3a
and not in LCR22-4. This observation argues against a
direct and simple link between high AHR and NAHR lev-
els. Other potential factors that might influence the partic-
ipation of an LCR22 in a NAHR event may be, for
example, the specific organization and content of each
LCR (tandem versus inverted repeats), as well as the size
and distance between the participating LCR22s.BMC Medical Genetics 2007, 8:14 http://www.biomedcentral.com/1471-2350/8/14
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The genomic diseases, Charcot-Marie-Tooth disease type
1A (CMT1A, MIM 118220) and hereditary neuropathy
with liability to pressure palsies (HNPP, MIM 161500) are
caused by LCR-mediated duplications and deletions in
17p12. de novo CMT1A duplication occurs 10 times more
frequently in male than in female gametogenesis and AHR
frequencies in the CMT1A/HNPP region indicate that the
frequency is low in males but high in females [13]. More-
over, a similar observation was made for the genomic
region that undergoes deletions causing the Smith-
Magenis syndrome (17p11.2, SMS; MIM 182290) where a
low rate of recombination was found in both sexes [14].
Comparison between the population-based linkage-disequilibrium map and the pedigree-based linkage map Figure 4
Comparison between the population-based linkage-disequilibrium map and the pedigree-based linkage map. 
A, An outline of the pedigree-based linkage map according to Figure 1. B, Population based linkage-disequilibrium SNP map. 
The map was constructed using genotype information publicly available from the HapMap project site http://www.hapmap.org, 
for a total of 2074 SNPs of 60 unrelated individuals corresponding to parents of the CEPH dataset (Utah residents with ances-
try from northern and western Europe; CEU). Background population recombination rate (ρ) per base pair and the factor by 
which the recombination rate between two adjacent SNPs exceeds the background rate (λ) were estimated for each window 
by the PHASE v2.1.1 software using the general model for recombination rate variation (-MR0 option). We plotted the ρ value 
for each window (red line) and the λρ value for each SNP interval (black line). C, The presence of a recombination hotspot 
was estimated for each window using the simple hotspot model for recombination (-MR1 option). We estimated ρ and λ inside 
the hot spot region and the hot spot boundaries defined by their left and right ends and plotted the λρ value across each win-
dow (black lines).BMC Medical Genetics 2007, 8:14 http://www.biomedcentral.com/1471-2350/8/14
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Hotspot prediction and comparison between historical and contemporary recombination rates in two regions of high marker  density in the pedigree-based map Figure 5
Hotspot prediction and comparison between historical and contemporary recombination rates in two regions 
of high marker density in the pedigree-based map. Charts a-d are for the region between positions 17,80 and 18,40 Mb 
and e-h for the region between positions 20,60 and 21,00 Mb. In all charts recombination rates based on family data are shown 
in red. Charts a and e shows the prediction of hotspot intensity and location (PHASE 2.1.1 software, -MR1 option) in the 
region. Charts b and f show population recombination rate profile (PHASE 2.1.1 software, -MR0 option) based on our analysis. 
Charts c and g show population recombination rate profiles as shown in the UCSC genome web tracks based on Hapmap 
data. Charts d and h show population recombination rate profiles as shown in the UCSC genome web tracks based on Perle-
gen data.BMC Medical Genetics 2007, 8:14 http://www.biomedcentral.com/1471-2350/8/14
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These observations led to the hypothesis that such
reduced recombination may increase unequal crossing
over by favoring misalignments [1].
Our study shows that LCR22s implicated in deletions and
duplications are sites of frequent meiotic recombination
(AHR) and that average recombination in the 22q11.2
region is similar to the chromosome average. Thus, aber-
rant recombination leading to 22q11.2 deletion syn-
drome can't be explained exclusively under a hypothesis
of low regional AHR rates. This may reflect that the mech-
anisms causing NAHR in the 22q11.2 region and those in
the regions causing SMS and CMT1A-HNPP may be differ-
ent; or that available maps of the the 17p11-12 region do
not have the resolution to determine AHR rates within the
region's LCRs. Comprehensive high resolution maps of
the 17p11-12 region may help solve this question.
Pedigree and haplotype data of a family with a member affected with the del22q11.2 syndrome and carrying the 3 Mb deletion  caused by an interchromosomal NAHR event Figure 6
Pedigree and haplotype data of a family with a member affected with the del22q11.2 syndrome and carrying 
the 3 Mb deletion caused by an interchromosomal NAHR event. The NAHR event was of maternal origin and in the 
previous generation there is a female AHR event within LCR22-2 that did not cause a deletion. The AHR event has been arbi-
trarily assigned to the mother of the deleted child.BMC Medical Genetics 2007, 8:14 http://www.biomedcentral.com/1471-2350/8/14
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In addition, we also show that AHR events within the
22q11.2 region cluster in families. If a concordance
between AHR and NAHR exists, we would expect families
with high AHR levels to be more prone to deletions and
duplications. Although we would need a large number of
multiple generation pedigrees to prove this, we describe
here a family with two female crossovers within LCR22-2:
in one generation it was an AHR event and in the next gen-
eration a NAHR event that resulted in a 22q11.2 deletion.
We have not found differences in allelic frequencies of
markers within 22q11.2 between individuals which show
AHR and those that do not. However, it has been seen that
the genetic background outside of a particular region
influences recombination rates and breakpoint location
[17,34]. Thus, it would not be surprising that the overall
genetic background may have an effect on a slightly larger
susceptibility to suffer rearrangements if NAHR and AHR
are mechanistically related. If that is the case, the observed
familial differences in recombination rates within the
22q11.2 region would have obvious health-related impli-
cations and certain families may have a slightly larger risk
to suffer a 22q11.2 deletion. However, because the genetic
or molecular factors that make 22q11.2 "hotter" for
recombination are unknown the quantification of such
risk is impossible right now.
In any case, further characterization of recombination in
the 22q11.2 region should provide more information on
a potential relation between NAHR and AHR active
regions. However, high throughput studies that could
clarify if AHR and NAHR show the same breakpoint loca-
tions are hampered by the recombinational and genomic
traits of the 22q11.2 region. On one hand, LCR22s are
large (300–400 kb) highly identical structures (>98%
identity) making it very difficult to identify reliable poly-
morphisms that would allow localization of AHR break-
points. And on the other hand, some of the most active
LCR22s in NAHR and AHR may have higher female than
male recombination rates, and thus sperm typing may not
be the ideal technique to characterize AHR within these
repeats.
Conclusion
We present a high resolution recombination map of the
22q11.2 region based on pedigree data. Our map allows
the location of recombination breakpoints with a high
resolution (potential recombination hotspots), and this
approach has led to the identification of 5 breakpoint seg-
ments of 50 kb or less (8.6 kb the smallest), that coincide
with historical hotspots. It has been suggested that aber-
rant recombination leading to deletion (and duplication)
is caused by low rates of Allelic Homologous Recombina-
tion (AHR) within the affected region [1]. Our study
shows that LCR22s implicated in deletions and duplica-
tions are sites of frequent meiotic recombination (AHR)
and that average recombination in the 22q11.2 region is
similar to the chromosome average. Thus, aberrant
recombination leading to 22q11.2 deletion syndrome
can't be explained exclusively under a hypothesis of low
AHR rates. In addition, we find recombination events in
the 22q11.2 region to cluster within families. Within this
context, the same chromosome recombines twice in one
family; first by AHR and in the next generation by NAHR
resulting in an individual affected with the del22q11.2
syndrome.
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Recombination events per family within the Typically Deleted  Region (TDR) in a sample of 18 large families with 10 or  more meiosis analyzed Figure 7
Recombination events per family within the Typically 
Deleted Region (TDR) in a sample of 18 large fami-
lies with 10 or more meiosis analyzed. Observed values 
are statistically different from those expected under a Pois-
son distribution (χ2 = 13.06, 2 df; P = 0.0016 and Mean dis-
tance test of Poissonity, P = 0.0033). We take this to indicate 
that some families have a higher tendency to recombine 
within the TDR region than others.BMC Medical Genetics 2007, 8:14 http://www.biomedcentral.com/1471-2350/8/14
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